Home › Funds › Propel Bio Management, LLC › OBIO
Propel Bio Management, LLC position in OBIO
ORCHESTRA BIOMED HLDGS INC · Health Care
Propel Bio Management, LLC reported holding 896,701 shares of OBIO (ORCHESTRA BIOMED HLDGS INC) in its Q3 2026 13F filing — a position valued at US$5.6M, representing 2.96% of its reported portfolio and ranking #10 among its reported holdings. Propel Bio Management, LLC has disclosed OBIO holdings in 3 of the last 3 reported quarters, going back to Q1 2026.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Propel Bio Management, LLC's OBIO position evolved
Propel Bio Management, LLC first disclosed a stake in OBIO in Q1 2026 at 896,701 shares (US$3.8M). The position peaked in Q3 2026 at 896,701 shares, worth US$5.6M. Across 3 filings, Propel Bio Management, LLC held the position steady without any share-count change. The most recent filing (Q3 2026) shows 896,701 shares valued at US$5.6M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 896.70K | $3.83M | New |
| Q2 2026 | 896.70K | $3.87M | Hold |
| Q3 2026 | 896.70K | $5.58M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About OBIO and 13F data
OBIO (ORCHESTRA BIOMED HLDGS INC) is a Health Care company. 42 other funds we track also report a position in OBIO — the largest reported positions include RTW INVESTMENTS, LP (US$41.2M), Knott David M Jr (US$1.6M), Flat Footed LLC (US$1.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding OBIO
- RTW INVESTMENTS, LP 9.56M sh · $41.23M · Q2 2026
- Knott David M Jr 253.65K sh · $1.58M · Q3 2026
- Flat Footed LLC 251.37K sh · $1.08M · Q2 2026
- Daytona Street Capital LLC 123.15K sh · $743.81K · Q3 2026
More on Propel Bio Management, LLC
FAQ
How long has Propel Bio Management, LLC held OBIO?
Propel Bio Management, LLC has disclosed OBIO holdings in 3 of the last 3 reported quarters, going back to Q1 2026.
What is Propel Bio Management, LLC's current position in OBIO?
As of Q3 2026, Propel Bio Management, LLC holds 896.70K shares of OBIO (ORCHESTRA BIOMED HLDGS INC), valued at $5.58M, representing 2.96% of its reported portfolio and ranking #10.
Has Propel Bio Management, LLC been buying or selling OBIO?
In the latest 13F filing (Q3 2026), Propel Bio Management, LLC held unchanged its position in OBIO. The position peaked in Q3 2026 at 896.70K shares.
Which other funds hold OBIO?
Other major institutional holders of OBIO include RTW INVESTMENTS, LP, Knott David M Jr, Flat Footed LLC, among 42 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.